MIRD pamphlet No. 24

Guidelines for quantitative 131I SPECT in dosimetry applications

Yuni K. Dewaraja, Michael Ljungberg, Alan J. Green, Pat B. Zanzonico, Eric Frey, Wesley E. Bolch, A. Bertrand Brill, Mark Dunphy, Darrell R. Fisher, Roger W. Howell, Ruby F. Meredith, George Sgouros, Barry W. Wessels

Research output: Contribution to journalArticle

Abstract

The reliability of radiation dose estimates in internal radionuclide therapy is directly related to the accuracy of activity estimates obtained at each imaging time point. The recently published MIRD pamphlet no. 23 provided a general overview of quantitative SPECT imaging for dosimetry. The present document is the first in a series of isotopespecific guidelines that will follow MIRD 23 and focuses on one of the most commonly used therapeutic radionuclides, 131I. The purpose of this document is to provide guidance on the development of protocols for quantitative 131I SPECT in radionuclide therapy applications that require regional (normal organs, lesions) and 3-dimensional dosimetry. COPYRIGHT

Original languageEnglish (US)
Pages (from-to)2182-2188
Number of pages7
JournalJournal of Nuclear Medicine
Volume54
Issue number12
DOIs
StatePublished - Dec 1 2013

Fingerprint

Pamphlets
Single-Photon Emission-Computed Tomography
Radioisotopes
Guidelines
Therapeutics
Radiation

Keywords

  • MIRD
  • Quantitative SPECT
  • SPECT/CT, dosimetry

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

Dewaraja, Y. K., Ljungberg, M., Green, A. J., Zanzonico, P. B., Frey, E., Bolch, W. E., ... Wessels, B. W. (2013). MIRD pamphlet No. 24: Guidelines for quantitative 131I SPECT in dosimetry applications. Journal of Nuclear Medicine, 54(12), 2182-2188. https://doi.org/10.2967/jnumed.113.122390

MIRD pamphlet No. 24 : Guidelines for quantitative 131I SPECT in dosimetry applications. / Dewaraja, Yuni K.; Ljungberg, Michael; Green, Alan J.; Zanzonico, Pat B.; Frey, Eric; Bolch, Wesley E.; Brill, A. Bertrand; Dunphy, Mark; Fisher, Darrell R.; Howell, Roger W.; Meredith, Ruby F.; Sgouros, George; Wessels, Barry W.

In: Journal of Nuclear Medicine, Vol. 54, No. 12, 01.12.2013, p. 2182-2188.

Research output: Contribution to journalArticle

Dewaraja, YK, Ljungberg, M, Green, AJ, Zanzonico, PB, Frey, E, Bolch, WE, Brill, AB, Dunphy, M, Fisher, DR, Howell, RW, Meredith, RF, Sgouros, G & Wessels, BW 2013, 'MIRD pamphlet No. 24: Guidelines for quantitative 131I SPECT in dosimetry applications', Journal of Nuclear Medicine, vol. 54, no. 12, pp. 2182-2188. https://doi.org/10.2967/jnumed.113.122390
Dewaraja, Yuni K. ; Ljungberg, Michael ; Green, Alan J. ; Zanzonico, Pat B. ; Frey, Eric ; Bolch, Wesley E. ; Brill, A. Bertrand ; Dunphy, Mark ; Fisher, Darrell R. ; Howell, Roger W. ; Meredith, Ruby F. ; Sgouros, George ; Wessels, Barry W. / MIRD pamphlet No. 24 : Guidelines for quantitative 131I SPECT in dosimetry applications. In: Journal of Nuclear Medicine. 2013 ; Vol. 54, No. 12. pp. 2182-2188.
@article{0607886483c14ad5b6c7a664471ea743,
title = "MIRD pamphlet No. 24: Guidelines for quantitative 131I SPECT in dosimetry applications",
abstract = "The reliability of radiation dose estimates in internal radionuclide therapy is directly related to the accuracy of activity estimates obtained at each imaging time point. The recently published MIRD pamphlet no. 23 provided a general overview of quantitative SPECT imaging for dosimetry. The present document is the first in a series of isotopespecific guidelines that will follow MIRD 23 and focuses on one of the most commonly used therapeutic radionuclides, 131I. The purpose of this document is to provide guidance on the development of protocols for quantitative 131I SPECT in radionuclide therapy applications that require regional (normal organs, lesions) and 3-dimensional dosimetry. COPYRIGHT",
keywords = "MIRD, Quantitative SPECT, SPECT/CT, dosimetry",
author = "Dewaraja, {Yuni K.} and Michael Ljungberg and Green, {Alan J.} and Zanzonico, {Pat B.} and Eric Frey and Bolch, {Wesley E.} and Brill, {A. Bertrand} and Mark Dunphy and Fisher, {Darrell R.} and Howell, {Roger W.} and Meredith, {Ruby F.} and George Sgouros and Wessels, {Barry W.}",
year = "2013",
month = "12",
day = "1",
doi = "10.2967/jnumed.113.122390",
language = "English (US)",
volume = "54",
pages = "2182--2188",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "12",

}

TY - JOUR

T1 - MIRD pamphlet No. 24

T2 - Guidelines for quantitative 131I SPECT in dosimetry applications

AU - Dewaraja, Yuni K.

AU - Ljungberg, Michael

AU - Green, Alan J.

AU - Zanzonico, Pat B.

AU - Frey, Eric

AU - Bolch, Wesley E.

AU - Brill, A. Bertrand

AU - Dunphy, Mark

AU - Fisher, Darrell R.

AU - Howell, Roger W.

AU - Meredith, Ruby F.

AU - Sgouros, George

AU - Wessels, Barry W.

PY - 2013/12/1

Y1 - 2013/12/1

N2 - The reliability of radiation dose estimates in internal radionuclide therapy is directly related to the accuracy of activity estimates obtained at each imaging time point. The recently published MIRD pamphlet no. 23 provided a general overview of quantitative SPECT imaging for dosimetry. The present document is the first in a series of isotopespecific guidelines that will follow MIRD 23 and focuses on one of the most commonly used therapeutic radionuclides, 131I. The purpose of this document is to provide guidance on the development of protocols for quantitative 131I SPECT in radionuclide therapy applications that require regional (normal organs, lesions) and 3-dimensional dosimetry. COPYRIGHT

AB - The reliability of radiation dose estimates in internal radionuclide therapy is directly related to the accuracy of activity estimates obtained at each imaging time point. The recently published MIRD pamphlet no. 23 provided a general overview of quantitative SPECT imaging for dosimetry. The present document is the first in a series of isotopespecific guidelines that will follow MIRD 23 and focuses on one of the most commonly used therapeutic radionuclides, 131I. The purpose of this document is to provide guidance on the development of protocols for quantitative 131I SPECT in radionuclide therapy applications that require regional (normal organs, lesions) and 3-dimensional dosimetry. COPYRIGHT

KW - MIRD

KW - Quantitative SPECT

KW - SPECT/CT, dosimetry

UR - http://www.scopus.com/inward/record.url?scp=84893349872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893349872&partnerID=8YFLogxK

U2 - 10.2967/jnumed.113.122390

DO - 10.2967/jnumed.113.122390

M3 - Article

VL - 54

SP - 2182

EP - 2188

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 12

ER -